Chemotherapy for pancreatic cancer — what it does, and when it is used

People who type chemotherapy pancreatic cancer into a search box are usually asking one of three quite different questions. Has it been offered because there is still a chance of cure? Has it been offered because an operation is not possible? Or is it being offered because nothing else is left? Chemotherapy does a genuinely different job in each of those situations, and working out which job it is doing for you is the most useful thing to settle before the first cycle.

Chemotherapy is drug treatment that travels in the bloodstream and reaches the whole body. That matters more in pancreatic cancer than in most cancers, because tumour cells commonly travel beyond the pancreas early, well before any scan can show them. An operation deals with what can be seen. Systemic treatment deals with what cannot. This is why chemotherapy is recommended alongside surgery even when the rest of the scan looks clear, and why it is the backbone of pancreatic cancer care rather than an add-on to it. The complete pancreatic cancer guide covers how diagnosis, surgery and supportive care fit around it.

It is worth saying plainly what chemotherapy is not. It is not a last resort, and being offered it does not mean an operation has been ruled out — in many plans it comes first precisely so that an operation becomes possible. It is also not the same conversation for every person. The same tumour at the same stage can lead to two very different plans depending on how well someone is, what the bile duct is doing, and what the genetic testing shows.

The rest of this page sets out the three settings chemo is used in, what actually decides which treatment you are offered, how a course is run week by week, and which parts of that pathway CION delivers itself.

• Is this course a cure attempt or a control plan? Both are legitimate. Knowing which one you are on changes how you read every scan that follows.
• How many cycles before the next scan? Ask for the reassessment point in advance, and for what result would change the plan.
• Am I fit enough for the more intensive option? The honest answer may be no. A gentler course completed in full is worth more than an intensive one abandoned after a cycle or two.
• Has germline testing been sent, and has the tumour been profiled? The results can change the class of treatment, so ask at the start rather than after several cycles.
• Would radiation be added at any point? For a tumour that cannot be removed, radiation sometimes follows a period of systemic treatment — including SBRT, a tightly focused form of radiation.
• Is there a trial that fits my situation? Clinical trials in pancreatic cancer explains what taking part involves, and what it does not.

1. 1

   Confirm what the tumour actually is

   Systemic treatment is chosen on the pathology report, not on the scan alone. Tissue is usually obtained by endoscopic ultrasound with a fine-needle sample.

   Biopsy coordinated with specialist endoscopy partners
2. 2

   Stage it properly and baseline the markers

   A pancreatic-protocol contrast CT is read for the tumour's relationship to the vessels behind the pancreas, with CA 19-9 and routine bloods taken at the start so the trend can be followed. PET-CT, where it is needed, is arranged with partner centres.

   CT, MRI/MRCP, CA 19-9 and bloods in-house at CION
3. 3

   Settle the operation question first

   Whether an operation is possible now, possible later, or not possible at all is what decides what the chemotherapy is for. Why surgery is not always possible sets out how that call is made and by whom.

   Tumour board at CION
4. 4

   Clear the way before treatment starts

   A blocked bile duct is drained first, and a blocked duodenum is dealt with before cycles begin — see biliary stenting for jaundice and duodenal stenting for obstruction. Nutrition and pancreatic enzyme support start at the same point, not later.

   Stenting coordinated with endoscopy partners; nutrition and enzyme support in-house at CION
5. 5

   Give the treatment

   Cycles are delivered in day care by our medical oncology team, with bloods before each cycle, written instructions for the days in between, and a number to call if something changes at home.

   In-house at CION across 35+ centres
6. 6

   Reassess, then adjust

   Scans and the CA 19-9 trend are reviewed at points agreed in advance. Treatment may continue, change class, drop to a maintenance approach, or make room for radiation. A tumour that has become operable goes back to the surgical partners for a fresh decision.

   Radiation and chemoradiation in-house at CION

Being clear about this early saves a difficult conversation later. Your first consultation is free and lasts 45 minutes, and it is a genuine review of your reports rather than a booking appointment.

Delivered in-house at CION, across 35+ centres in Telangana and Andhra Pradesh: chemotherapy in every setting on this page — before surgery, after surgery and for advanced disease; PARP-inhibitor-class maintenance where an inherited BRCA-type change is found; immune checkpoint inhibitor therapy where the tumour is mismatch-repair deficient; systemic treatment for neuroendocrine tumours, including somatostatin-analogue-class therapy. Also radiation, chemoradiation and SBRT; the ordering and reporting of pancreatic-protocol CT, MRI/MRCP, CA 19-9 and bloods; genetic counselling; nutrition and pancreatic enzyme replacement; pain relief, psycho-oncology and supportive care; and survivorship follow-up. Pancreatic cancer treatment in Hyderabad sets out the whole pathway in one place.

Coordinated with specialist HPB, gastroenterology, endoscopy and nuclear medicine partner centres, and may be billed there: all pancreatic surgery; endoscopic ultrasound with biopsy; ERCP and biliary or duodenal stenting; staging laparoscopy; coeliac plexus block for pain; PET-CT and DOTATATE PET; and peptide receptor radionuclide therapy. We arrange these, we sit in on the decisions, and we tell you in advance where each one happens and who invoices you. We do not describe them as our own theatre or endoscopy lists, because they are not.

Chemotherapy has side effects. Most are manageable, and all of them are easier to manage when they are expected. The common ones are tiredness that builds across a course, nausea, a dip in blood counts in the days after each cycle, mouth soreness, changes in taste, and hair thinning with some classes of treatment. Certain classes cause tingling or numbness in the fingers and toes, which is checked at every visit because it is the side effect most likely to change a dose. Bloods before each cycle exist for the same reason.

Pancreatic cancer brings problems of its own that sit alongside treatment. When the pancreas cannot release enough digestive enzymes, food passes through poorly and weight falls even when meals look adequate; enzyme replacement corrects that and is part of treatment, not an optional extra. Blood sugar can rise for the first time or become harder to control, which is sometimes called type 3c diabetes. Both are handled in-house, and both matter, because staying nourished is what allows a full course of treatment to be completed on schedule.

Pain deserves its own mention. Pancreatic pain that goes through to the back often answers better to a nerve block than to steadily escalating tablets, and asking about it early is reasonable rather than dramatic. Coeliac plexus block for pancreatic cancer pain explains what that involves; it is performed by partner endoscopy or pain teams and may be billed at their centre.

Medical disclaimer: This page explains the role chemotherapy plays in pancreatic cancer and how a course is planned and reassessed, and is reviewed by a CION medical oncologist with reference to NCCN guidance on pancreatic adenocarcinoma. It is general information and not a treatment recommendation for any individual; the right plan for you depends on your resectability category, tumour type, general health and test results, and must be decided with your treating team. No drug, regimen or trial is named here by design. Chemotherapy in every setting, radiation, chemoradiation and SBRT, the ordering and reporting of pancreatic-protocol CT, MRI/MRCP, CA 19-9 and bloods, genetic counselling, nutrition and pancreatic enzyme (PERT) support, pain relief, psycho-oncology and survivorship follow-up are delivered by CION. All pancreatic surgery, endoscopic ultrasound and biopsy, ERCP and biliary or duodenal stenting, staging laparoscopy, coeliac plexus block, PET-CT and DOTATATE PET, and peptide receptor radionuclide therapy are coordinated with specialist hepatobiliary, gastroenterology, endoscopy and nuclear medicine partner centres and may be billed there.